DEMO

Log In | Sign Up



West Pharmaceutical Services

Selected Articles

2025-07-29
ETF Daily News
West Pharmaceutical Services, Inc. (NYSE:WST) Receives $320.71 Consensus Target Price from Analysts
2025-07-29
ETF Daily News
William Blair Has Bullish Forecast for WST Q3 Earnings
2025-07-28
ETF Daily News
West Pharmaceutical Services (NYSE:WST) Price Target Raised to $320.00
2025-07-27
ETF Daily News
West Pharmaceutical Services (NYSE:WST) Price Target Raised to $350.00 at Evercore ISI
2025-07-26
ETF Daily News
Victory Capital Management Inc. Sells 16,247 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
2025-07-26
ETF Daily News
West Pharmaceutical Services (NYSE:WST) Stock Rating Upgraded by Wall Street Zen
2025-07-26
ETF Daily News
West Pharmaceutical Services (NYSE:WST) Shares Gap Up After Better-Than-Expected Earnings
2025-07-25
Fortune
AT&T's CFO and CMO have key advice on how to think about marketing
2025-07-25
ETF Daily News
HighPoint Advisor Group LLC Sells 308 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
2025-07-25
CFO Magazine
CFOs On the Move: Week ending July 25

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania. US9553061055 www.westpharma.com